Characterization and Validation of Arg286 Residue of IL-1RAcP as a Potential Drug Target for Osteoarthritis is a research paper published in Frontiers in Chemistry (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AR068436
National Institutes of Health
Grant: R21CA177535
National Institutes of Health
Grant: R33CA173359
National Institutes of Health
Grant: R33CA206937
National Institutes of Health
Grant: 5R33CA173359-02
Nanotrap technology for one step preservation and amplification of cancer biomark
National Institutes of Health
Grant: 5R21CA177535-02
Protein Painting reveals hidden protein-protein interaction domains
National Institutes of Health
Grant: 5R33CA206937-03
Protein painting identifies therapeutic targets at protein-protein interfaces
National Institutes of Health
Grant: 5R01AR068436-03
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation
Center for Innovative Technology
Virginia Biosciences Health Research Corporation
Fields of Study
Keywords
Sustainable Development Goals